Page 3 - Innovation Layer News Today

Cue Health Inc. (NASDAQ:HLTH – Get Rating) saw a significant decrease in short interest in March. As of March 15th, there was short interest totalling 2,750,000 shares, a decrease of 8.0% from the February 28th total of 2,990,000 shares. Approximately 3.2% of the shares of the stock are short sold. Based on an average daily […]

Should You Buy or Sell Cue Health Stock? Get The Latest HLTH Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

Accelerate Diagnostics (NASDAQ:AXDX – Get Rating) and Cue Health (NASDAQ:HLTH – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends. Insider and Institutional Ownership 65.5% of Accelerate Diagnostics shares […]

Coherent (NASDAQ:COHR – Get Rating) and Cue Health (NASDAQ:HLTH – Get Rating) are both computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, valuation, profitability and analyst recommendations. Earnings and Valuation This table compares Coherent and Cue […]

Cue Health (NASDAQ:HLTH – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Cue Health Inc. is a health technology company. It offers individuals, enterprises, government agencies and healthcare provides access to lab-quality diagnostic testing at home, […]

Cue Health (NASDAQ:HLTH – Get Rating) and Codex DNA (NASDAQ:DNAY – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, analyst recommendations, profitability, risk and dividends. Profitability This table compares Cue Health and Codex DNA’s […]

Codex DNA (NASDAQ:DNAY – Get Rating) and Cue Health (NASDAQ:HLTH – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations and dividends. Insider and Institutional Ownership 87.6% of Codex DNA shares […]

Equities analysts expect Cue Health Inc. (NASDAQ:HLTH – Get Rating) to announce ($0.50) earnings per share for the current quarter, according to Zacks. Zero analysts have made estimates for Cue Health’s earnings. The company is scheduled to issue its next quarterly earnings results on Monday, January 1st. According to Zacks, analysts expect that Cue Health […]